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Interictal psychosis: a case 
report and review
Psicose interictal: relato de 
caso e revisão de literatura
Dear Editor,
Epilepsy is the most prevalent of the potentially ominous 
neurological disorders, affecting over 50 million individuals 
worldwide, 80% of them living in developing countries.1 
Accordingly, epilepsy represents a significant public health issue.2 
Epilepsy and mental disorders are comorbid, and from 19 to 52% 
of adults with epilepsy have psychiatric disorders.3 Psychiatric 
disorders can be identified in 25-50% of patients with epilepsy, 
with higher prevalence among patients with poorly controlled 
seizures. These disturbances include depression, anxiety, psychotic 
disorders, cognitive, and personality changes occurring in the 
interictal or ictal/postictal states.4 
Herein we report the case of a patient with epilepsy since the age 
of 10 years. At the age of 34, he claimed he suddenly discovered 
the “mystery of the words”, as well as “the art of writing, the gift 
of demagogy, nationalism, politics and romance”. He developed 
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paranoid symptoms. At this time he reported that his “ego” started 
turning against him. He could hear his own voice, cursing him 
continuously and telling him to do various things such as eating 
someone’s excrements. He said he was sure that this was his ego 
since he had studied psychoanalysis extensively and had “self-
knowledge”.
He remained without treatment until he was 41, when he 
initiated psychiatric treatment, being prescribed Haloperidol 
10mg/day and Biperiden 4mg/day. He felt calmer at the 
beginning, but eventually became progressively more disturbed, 
feeling that not only his ego, but also his soul, superego, id and 
personality progressively turned against him. 
In December 2006, aged 46, he presented to the Mood Disorders 
Unit (GRUDA), School of Medicine of the Universidade de São 
Paulo and was admitted for inpatient investigation and treatment. 
As clinical antecedents he had a previous exploratory laparotomy, 
blood hypertension, diabetes, and obesity. The psychiatric exam 
revealed an apathetic patient, not receptive to contact. He had 
blunted affect, even when stimulated with humor. He responded 
with brief answers and recurrently talked about being persecuted, 
claiming that his ego took away the “emotions” from his bowels, 
making him evacuate. He also complained of weakness on his 
legs, and justified it as the consequence of his ego and superego 
making him unable to walk. 
Subsidiary tests (including serological tests for HIV, syphilis and 
hepatitis) were all normal. Electroencephalogram showed epileptic 
activity with continuous discharges on the temporal regions, 
bilaterally. Magnetic resonance suggested right mesial temporal 
lobe sclerosis (Figure 1). Neuropsychological evaluation revealed 
impairments in areas related to attention, language, visual-spatial 
organization, planning, memory and executive functions.
Patient was using Carbamazepine 600mg tid, Phenobarbital 
200mg tid and Clonazepam 2mg tid. He was also using 
Haloperidol, Biperiden and Promethazine, all of them were 
suspended. Carbamazepine was increased to 800mg tid and 
Ziprasidone was started at 80mg and titrated to 240mg tid over 
3 weeks. Carbamazepine was switched to Oxcarbazepine 1200mg 
tid, for a better drug interaction profile.
He maintained tonic-clonic seizures, once every 2 months. 
During treatment he progressively developed better contact, 
greater affective tonus and variability as well as a reactive mood. 
Although full remission of the psychotic disorder and of epilepsy 
were not achieved, treatment significantly improved the functional 
impact of these disorders.
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